Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 481 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

Hyundai Hope On Wheels Presents University Hospitals Rainbow Babies & Children's Hospital With $200,000 Hyundai Young Investigator Grant To Support Pediatric Cancer Research

CLEVELAND, Sept. 12, 2019 /PRNewswire/ -- Hyundai Hope On Wheels® (HHOW), a 501(c)(3) non-profit organization... Read more ››

By: PR Newswire Association LLC. - 12 Sep 2019

Christopher & Dana Reeve Foundation to Hold Webinar on The Rights Of Residents In Long-Term Care Facilities

SHORT HILLS, N.J., Sept. 12, 2019 /PRNewswire/ -- The Christopher & Dana Reeve Foundation... Read more ››

By: PR Newswire Association LLC. - 12 Sep 2019

Karmanos Cancer Institute's Partners Night 2019, Friday, Sept. 20, honors the LaFontaine Family

DETROIT, Sept. 12, 2019 /PRNewswire/ -- The Barbara Ann Karmanos Cancer Institute will celebrate its Read more ››

By: PR Newswire Association LLC. - 12 Sep 2019

ViewRay Announces Collaboration with Stanford Health Care

CLEVELAND, Sept. 12, 2019 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that Stanford Health Care in Stanford, California, will acquire a MRIdian, the world's leading MR-guided radiation therapy system.

Read more ››
By: PR Newswire Association LLC. - 12 Sep 2019
Related companies:  ViewRay, Inc.

Accuray Appoints Healthcare Veteran James M. Hindman to Board of Directors

SUNNYVALE, Calif., Sept. 12, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) strengthened its Board of Directors with the appointment of James (Jim) M. Hindman, effective as of September 6, 2019, and expanding the company's Board to nine members. Mr. Hindman, an experienced healthcare... Read more ››

By: PR Newswire Association LLC. - 12 Sep 2019
Related companies:  Accuray Incorporated

Varian Announces Fourth Quarter Fiscal Year 2019 Earnings Release Date

PALO ALTO, Calif., Sept. 12, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced its fourth quarter fiscal year 2019 earnings release date.

Read more ››
By: PR Newswire Association LLC. - 12 Sep 2019
Related companies:  Varian Medical Systems, Inc.

AARC Supports Administration's Decision to Remove Flavored E-Cigarettes from the Market

IRVING, Texas, Sept. 12, 2019 /PRNewswire/ -- The American Association for Respiratory Care (AARC) strongly supports the Administration's announcement on September 11 regarding its plans to remove flavored e-cigarettes from the marketplace and commends its actions to protect our nation's youth... Read more ››

By: PR Newswire Association LLC. - 12 Sep 2019

Medifast, Inc. Announces Quarterly Dividend

BALTIMORE, Sept. 12, 2019 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), a leading manufacturer and distributor of clinically proven programs and healthy living products, announced today that its Board of Directors has declared a $0.75 cash dividend to its stockholders. The quarterly cash... Read more ››

By: PR Newswire Association LLC. - 12 Sep 2019
Related companies:  Medifast, Inc.

China Finasteride Market Report 2019-2023

DUBLIN, Sept. 12, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 12 Sep 2019

Qfix® Announces FDA 510(k) Clearance of Encompass(TM) 15 Channel Head Coil for Siemens 3T MRI Systems

AVONDALE, Pa., Sept. 12, 2019 /PRNewswire/ -- Qfix has received FDA 510(k) clearance for the Encompass 15-Channel Head Coil, a diagnostic imaging device optimized for use with the Encompass(TM) MR SRS Immobilization Device.

Read more ››
By: PR Newswire Association LLC. - 12 Sep 2019
Related companies:  Qfix

Global Drug Delivery Partnering Deal Trends, Players and Financials Directory 2014-2019

DUBLIN, Sept. 12, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 12 Sep 2019

Independent Pharmacies Win 2019 Digital Excellence Awards

AUSTIN, Texas, Sept. 12, 2019 /PRNewswire/ -- Digital Pharmacist (www.digitalpharmacist.com), a rapidly growing software... Read more ››

By: PR Newswire Association LLC. - 12 Sep 2019

Growth Opportunities in the Neurodegenerative Disorder Therapeutics Market - Global Forecast to 2024

DUBLIN, Sept. 12, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 12 Sep 2019

Correvio Highlights FDA Acceptance of United Therapeutics' Trevyent New Drug Application

NASDAQ: CORV TSX: CORV

Read more ››
By: PR Newswire Association LLC. - 12 Sep 2019
Related companies:  Correvio Pharma Corp.

Valens Announces 5 Year White Label Cannabis Infused Beverage Contract with Iconic Brewing Company's Cannabis Division

KELOWNA, BC, Sept. 12, 2019 /PRNewswire/ - Valens GroWorks Corp. (TSXV: VGW) (OTCQX: VGWCF) (the "Company" or "Valens"), a vertically integrated provider of industry leading extraction products and services; including a diverse suite of extraction methodologies, next... Read more ››

By: PR Newswire Association LLC. - 12 Sep 2019
Related companies:  Valens GroWorks Corp.

Bridgeable Wins Prestigious Fast Company Innovation by Design Award in the Mobility Category

As Winner in the Mobility category, Bridgeable joins an influential and diverse group of 22 winners and 483 honorees in architecture, graphic design, data visualization, social good, user experience, mobility, and more--including Nike, Microsoft, Mastercard, Gensler, and other leading global... Read more ››

By: PR Newswire Association LLC. - 12 Sep 2019

InMed Pharmaceuticals to Report Fourth Quarter, and Full Year Fiscal 2019 Financial Results and Business Update on September 19, 2019

TSX:IN
OTCQX:IMLFF

Read more ››
By: PR Newswire Association LLC. - 12 Sep 2019
Related companies:  InMed Pharmaceuticals Inc.

TSO3 Inc. reminds shareholders to vote for the arrangement with Stryker

QUÉBEC CITY and MYRTLE BEACH, SC, Sept. 12, 2019 /PRNewswire/ - TSO(3) Inc. ("TSO(3)" or the "Company") (TSX: TOS) wishes to reiterate that shareholders should vote in favor of the proposed plan of arrangement (the "Arrangement") involving the Company, Stryker Corporation... Read more ››

By: PR Newswire Association LLC. - 12 Sep 2019
Related companies:  TSO3 Inc.

Strekin AG Announces Completion of Patient Recruitment in the RESTORE Phase 3 Clinical Study of STR001

BASEL, Switzerland, Sept. 12, 2019 /PRNewswire/ -- Strekin AG (www.strekin.com), a biopharmaceutical company focused on treatments for hearing loss, announced today that it has successfully completed patient recruitment in the RESTORE study, an international, randomized, placebo-controlled, Phase... Read more ››

By: PR Newswire Association LLC. - 12 Sep 2019
Related companies:  Strekin AG

10x Genomics Announces Pricing of Initial Public Offering

Read more ››
By: Nasdaq / GlobenewsWire - 12 Sep 2019
Related companies:  10X Genomics, Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑